COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
Vaccine
; 38(48): 7581-7584, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: covidwho-845859
ABSTRACT
Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2.
Palabras clave
Bacillus Calmette-Guérin (BCG); Coronavirus Disease 2019 (COVID-19); Corynebacterium parvum (C. parvum); Cutibacterium acnes (C. acnes); Hyaluronic acid; Propionibacterium acnes (P. acnes); Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); T helper 1 (T(h)1); T helper 2 (T(h)2); Vaccine; cluster of differentiation 44 (CD44)
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Propionibacteriaceae
/
Vacunas Bacterianas
/
Vacuna BCG
/
Infecciones por Coronavirus
/
Pandemias
/
Betacoronavirus
/
Inmunidad Innata
Tipo de estudio:
Estudio de etiologia
/
Estudio observacional
Tópicos:
Vacunas
Límite:
Humanos
Idioma:
Inglés
Revista:
Vaccine
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS